The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services
|
|
- Elisabeth McDowell
- 6 years ago
- Views:
Transcription
1 Standard Operating Procedure 2 (SOP 2) The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services Why we have a procedure? Black Country Partnership NHS Foundation Trust is committed to managing medicines safely, efficiently and effectively as a key component for the delivery of high quality patient centred care. Medicines play a significant role in the care of the people who use our services and creating an effective system for managing medicines in an appropriate and timely manner is key to giving patients the best possible care, positive outcomes and reducing incidents of harm. Administering medicines to people should not to be regarded as just a mechanical task to be carried out in line with the instructions of the prescriber, it requires thought, application and the exercise of professional judgement; it is a core component of medicines management and encompasses many areas for potential error. This standard operating procedure describes the procedures and best practice that should be used when providing IM Depot medication to a patient in the community, whether by prescribing, supplying or administering a product. It includes the professional standards that are expected of different staff groups and the personal responsibility and accountability involved. It covers all aspects of the process from accurate prescription writing to safe administration of the Depot medication. The purpose of this policy is to ensure that all staff dealing with medicines follow safe practice in the prescribing, requisition, storage, administration and control of medicinal products. It applies to all individuals employed or contracted by Black Country Partnership NHS Foundation NHS Trust including all locum and agency staff and to all activities relating to medicines use within in-patient, out-patient, community and any residential facilities. The objectives of this SOP are as follows: To comply with Care Quality Commission s essential standards for quality and safety that requires NHS providers to establish, document and maintain an effective system to ensure that medicines are handled in a safe and secure manner. To comply with nationally agreed standards set out in the Duthie Report, Crown Report, relevant medicines legislation and guidance from the UK Nursing and Midwifery Council and the General Medical Council. To define the process and procedures to be followed within Black Country Partnership Foundation NHS Trust for the prescribing, monitoring and Depot Medication within Community MH Services Page 1 of 16 Version 1.0 July 2017
2 administration of Depot medication within the Community and to ensure the highest standards of medicines management and minimise risks associated with the use of Depot medication. To promote a consistent and best practice approach to the safe administration of Depot medication, aligning practices over Wolverhampton and Sandwell community teams. What overarching policy the procedure links to? Medicines - Administration Policy Please note this policy should also be read in conjunction with: Medicines Prescribing Policy Medication Errors Policy Infection Control Policy Polar Speed SOP BNF General Medical Council Good practice in prescribed medicines (2008) September 2008 Nursing and Midwifery Council of Great Britain (2008). Standards for Medicines Management. Trust Policies can be found on the Trust Intranet site: If you cannot find the Policy you are looking for then please contact the relevant service manager. Which services of the trust does this apply to? Where is it in operation? Group Inpatients Community Locations Mental Health Services all Learning Disabilities Services all Children and Young People Services all Who does the procedure apply to? Medical Director (Executive Lead) Lead responsibility for the implementation of this Standard Operating Procedure. Allocation of resources to support the implementation of this Standard Operating Procedure Chair of the Trust s Medicines Management Committee The Medical Director is responsible for ensuring: The Trust s overall duty for medicines management is discharged appropriately A systematic and consistent approach for the safe and secure handling of medicines Chief Executive (Accountable) The Chief Executive is responsible for assuring that this Standard Operating Procedure is implemented within the Trust. Operational responsibility has been delegated. Depot Medication within Community MH Services Page 2 of 16 Version 1.0 July 2017
3 Chief Pharmacist (Lead) The Chief Pharmacist is responsible to the Medical Director for all aspects of the safe and secure handling of medicines within the Trust. Matrons/Service / Team Managers/ Trust Pharmacy Team (Day to Day Monitoring) To support the implementation and monitoring of this Standard Operating Procedure. To provide support and advice to all staff involved in the administration of medicines as necessary all incidents, complaints and claims relating to this area of practice and Standard Operating Procedure are reported. Clinical Directors, Divisional Directors, Divisional Managers (Operational Leadership) Responsible for implementing the specific clinical requirements of this Standard Operating Procedure. These specific responsibilities relate to professional conduct, clinical competence, training needs analysis, competence assessment and clinical decision making. In addition this group will be responsible for the day-to-day implementation of the Standard Operating Procedure ensuring that: All staff are aware of their role under the Standard Operating Procedure Staff have received sufficient training and/or are competent to implement the Standard Operating Procedure Appropriate SOP distribution, implementation and compliance throughout relevant teams and services within their group professional standards of record keeping are maintained Lead discussions around this topic area and SOP at Group Quality and Safety Group meetings Oversee the completion of audits in respect of this topic area and SOP Provide updates on this SOP within their Group to the Quality and Safety Steering Group Registered Clinical practitioners Clinical staff are familiar with the SOP and be responsible for adhering to the procedures referred to within the document: They are expected to also follow their own professional codes of practice in relation to medicines. These include: Medical: General Medical Council guidance on good medical practice. Nursing: NMC guidelines for the administration of medicines 2008 Pharmacy: General Pharmaceutical Council, Royal Pharmaceutical Society and the Medicines, Ethics and Practice. Medicines Management Committee (Scrutiny and Performance) Are responsible for: overseeing the governance of medicines management across the Trust receiving specific issues in relation to the delivery, development and monitoring of medicines management reviewing all policies, guidelines and procedures including PGD s, SOP s and prescribing documentation affecting drug use or medicines management Depot Medication within Community MH Services Page 3 of 16 Version 1.0 July 2017
4 When should the procedure be applied? This SOP should be adhered to and followed for the prescribing, monitoring and administration of Intra muscular Depot / Long Acting IM Medication for all Patients across all Planned Care community services within the mental health Division. How to carry out this procedure Processes The Prescribing of Depot / Long Acting IM medication The prescription for IM Depot medication for a Patient in the Community must be written on the Community Depot / Long Acting Injection Prescription and Administration Card that was approved by the Trust s Medicines Management Committee. Guidance on prescription writing provided in the BNF should be followed at all times. The Depot / Long Acting IM Medication Prescription must: Be appropriate, complete, unambiguous, legible and in capitals Be in black ink. Be signed and dated appropriately. Each prescription item must be validated by the full signature of a registered medical practitioner or authorised prescriber. The signature should be legible and the printed name of the prescriber should be written next to the signature. Initials or abbreviated signatures are not an adequate means of identification of a prescriber or serve as authorisation of a prescription. It is the responsibility of medical staffing to send specimen signatures of all authorised prescribers in the Trust, including Locums, on appointment, to the Pharmacy department and Community team managers. It is the responsibility of the Non-Medical Prescribing Lead to collate and send specimen signatures of all authorised Non-Medical Prescribers in the Trust, on appointment, to the Pharmacy department and Community team managers. Adhere to legal, formulary and Trust policy requirements Bear the full name, address, Date of Birth and NHS number of the patient (Patient information sticker can be used) Only use Trust approved abbreviations:- I.M for Intramuscular The prescriber to ensure that arrangements are in place for all test doses of Depot / Long Acting injections to be administered on Trust premises that have access to emergency life support equipment. It is the administering nurse s responsibility to challenge any queries / concerns relating to the prescription and raise with the Prescriber or a member of the Consultant medical team. This should be escalated as soon as possible to avoid any unnecessary delays in Patient care. The Depot / Long Acting IM Medication Prescription must include: Name of the Medicine The full generic form e.g. zuclopenthixol decanoate. The interval expressed using the word every (e.g. every 3 weeks; this can be abbreviated to every 3/52). The prescription dose should include appropriate use of decimal points. Depot Medication within Community MH Services Page 4 of 16 Version 1.0 July 2017
5 The date prescribed and the next due date if appropriate. Use of the phrase as directed is not acceptable. Explicit dosage instructions, including route and site of administration should be stated. Abbreviations of units should always be written in the singular, e.g. 10mg, not 10mgs. Validity of Community Prescriptions for Depot / Long Acting IM medication: The Depot / Long Acting IM medication prescription will remain valid for a maximum of 6 months. After this 6 month period, the prescription will be invalid. Verbal orders/prescriptions cannot be accepted for Depot / Long Acting IM medication for community Patients where the Community Depot / Long Acting Injection Prescription and Administration Card has not been written. Prior to the rewriting of the Community Depot / Long Acting Injection Prescription and Administration Card, the relevant Consultant medical secretary will check the date of the Patient s last outpatient appointment and communicate this to the Prescriber. The prescriber must ensure that the patient has had a face to face medical review within a maximum period of no more than 12 months. When a community Patient is admitted to an inpatient ward, the ward staff should notify the community team of the Patient s admission as soon as possible. A copy of the Community Depot / Long Acting Injection Prescription and Administration Card should be scanned and ed / faxed to the inpatient unit to confirm the last and due date of the Patient s Depot / LAI medication. The Community Depot / Long Acting Injection Prescription and Administration Card should then be discontinued and filed in the notes. The Community Depot / LAI Prescription and Administration Card should be completed on discharge by inpatient medical team and forwarded to the relevant community team. Each inpatient ward will have a stock of the Community Depot / LAI Prescription and Administration Cards that will be supplied by the relevant community team. Documentation of Allergies/Hypersensitivities All prescription forms must specify whether or not the patient has any allergies / hypersensitivities information (i.e. allergy details or No known drug allergy NKDA) on the prescription sheet, along with the source of information identified. Prescribing Incidents Prescribing incidents are defined as prescribing: The wrong medicine The wrong dose of medicine The wrong frequency The wrong route The wrong due date of administration outside of the acceptable window as agreed by the prescriber Failure to sign the prescription / patient allergies / Hypersensitivities. All prescribing incidents must be reported via the Trust Datix Incident Reporting System. The Divisional Risk team will ensure that the responsible consultant is informed of the incident and that this is formally addressed in accordance with the Trust medication error policy. Furthermore, Patient Duty of Candour notification and processes will be applied where appropriate. Depot Medication within Community MH Services Page 5 of 16 Version 1.0 July 2017
6 Initiation of Depot / LAI Medication Care should be taken to ensure that a test dose of Depot medication is prescribed where appropriate. This is not a requirement for LAI medication. Monitoring of Depot / Long Acting IM Medication Any noted deterioration in a Patient s mental or physical health should be escalated to the Responsible Clinician and, where deemed appropriate, medically reviewed at the earliest possibility by the relevant Consultant medical team. All Patients who are receiving Depot / Long Acting IM medication will receive an annual physical health check from the Planned Care Monitoring side-effects Prescribers must fully inform patients of possible side-effects / adverse drug reactions that could be caused by the medication prior to prescribing it (Choice & Medication leaflet). At each review prescribers must ask patients about and document any sideeffects they are experiencing. During every contact, the Registered Mental Health nurse, Medical Officer or a Nurse in training must actively ask patients about side-effects / adverse drug reactions that the patient may be experiencing. Registered Mental Health nurse, Medical Officer or a Nurse in training must record these in the patient s notes and ensure the prescribers are informed. Medical Reviews of Patients on Depot / Long Acting IM medication Prior to the completion or rewriting of a community Depot / Long Acting IM medication prescription, the prescriber must ensure that the patient has had a face to face medical review within a maximum period of no more than 12 months. Prescribers must fully inform patients of possible side-effects / adverse drug reactions that could be caused by the medication prior to prescribing it (Choice & Medication leaflet). The face to face medical review of the patient should include an assessment of the presence of any side-effects / adverse drug reactions that the patient may be experiencing. Details of any adverse effects relating to or suspected to relate to the administration of Depot / Long acting IM medication should be recorded in the patient s record and this information should be related to the prescriber. A yellow card should be filled in and sent to the MHRA. Yellow forms are available in the back of the BNF or at Administration of Depot / Long Acting IM Medication Depot / long acting IM medication must only be administered with a valid, a clearly written and unambiguous prescription, using the generic name of the medication, on the Trust approved community Depot / LAI prescription and administration Card. IM Depot / LAI medication must be administered by a Registered Mental Health nurse, Medical Officer or a Nurse in training under the direct supervision of a Registered Nurse The person who administers a medicine is responsible and accountable for his/her action / omission. IM Depot / LAI medication must be administered by a Registered Mental Health nurse, Medical Officer or a Nurse in training under the direct supervision of a Registered Nurse. Depot Medication within Community MH Services Page 6 of 16 Version 1.0 July 2017
7 The Registered Mental Health nurse, Medical Officer or a nurse in training under the direct supervision of a Registered nurse must ensure the following is in place prior to administering the Depot / LAI medication - Valid prescription - Correct Patient - Correct Depot / Long acting IM medication - Correct date - Correct dose The registered nurse responsible for the administration of the IM injection must ensure that any required calculation is correct. A second practitioner must check the calculation in order to minimise the risk of error. A test dose of Depot / Long Acting IM Medication should only be administered to inpatients or patients under the care of Crisis Home Treatment team (CHTT). Registered nurses responsible for the administration of the IM injection in a patient s own home (or outside of the Depot / LAI clinic) are exempt from the checking requirements due to the nature of the role and the safeguards in place. If there is any doubt about the content or clarity of a prescription the Registered Mental Health nurse, Medical Officer or a Nurse in training under the direct supervision of a Registered Nurse must contact the prescriber or deputy before proceeding to administer the Depot / Long acting IM injection. If there is still uncertainty a pharmacist must be contacted. In an emergency, if the prescriber is unable to attend, the Registered Mental Health nurse, Medical Officer or nurse in training under the direct supervision of a registered nurse may defer the administration of the medication until further clarification is obtained. The Registered Mental Health nurse, Medical Officer or a Nurse in training under the direct supervision of a Registered Nurse must ensure that all prescribed test doses of Depot / LAI medications are administered on Trust premises that have access to emergency life support equipment. Whilst under the care of the CHTT, the Depot / LAI medication for a community Patient will be administered by the Patient s care coordinator / CPN or within the community Depot / LAI clinic unless exceptional circumstance prevails and then the IM medication will be administered by a registered nurse within the CHTT. The administration of Depot / LAI medication for older adults under the care of the CHTT will be undertaken by registered nurses within the CHTT. Any noted deterioration in a Patient s mental or physical health should be escalated to the Responsible Clinician and, where deemed appropriate, medically reviewed at the earliest possibility by the relevant Consultant medical team. If the Registered Mental Health nurse, Medical Officer or a Nurse in training under the direct supervision of a Registered Nurse becomes aware of or observes an adverse drug reaction following the administration of the Depot / Long acting IM medication, he / she should contact the relevant medical team without the delay. Details of any adverse effects relating to or suspected to relate to the administration of Depot / Long acting IM medication should be recorded in the patient s record and this information should be related to the prescriber. A yellow card should be filled in and sent to the MHRA. Yellow forms are available in the back of the BNF or at Recording of Depot / Long Acting IM Medication Administration Each written entry should include the standards as outlined within the Trust clinical record keeping policy and NMC record keeping guidelines. Depot Medication within Community MH Services Page 7 of 16 Version 1.0 July 2017
8 Each entry should include: Prescribed medication administered Concordance and compliance Mental health presentation Expressed or observed adverse effects Next due date of administration Any other concerns voiced or noted within the consultation Completion of Community Depot/Long Acting Injection Prescription and Administration Card. All Community Depot/Long Acting Injection Prescription and Administration Cards for Patient s on Community Treatment Orders (CTO) should have the forms CTO 11/12 attached to the treatment card and the form should then be removed if the CTO is discontinued. All Community Depot/LAI Prescription and Administration Cards that are full, should be scored with a single diagonal line through the card. All records and copies of the Community Depot / LAI Prescription and Administration Cards must be permanently filed in the notes. Records should be completed immediately or at the earliest opportunity not exceeding 24 hours after the medication is administered, or if a dose is refused or wasted, this must also be recorded, signed and dated. Patient contact must be recorded electronically on all relevant IT systems within 3 working days as per Trust policy. All Patients on Depot / LAI medication will have a community records file that contains the following minimum standard: Demographic sheet Abbreviation sheet Care record booklet Completed consent to treatment form Any relevant clinical correspondence Any relevant CPA documentation Specimen Signatures / Initials Each Community mental health team should have an up to date nurse specimen signature list that is reviewed on a quarterly basis. A copy of this list should be forwarded to Pharmacy and a copy available within the team clinic / treatment rooms It is the responsibility of the team manager / Deputy to review and update the specimen signature list on a quarterly basis Retention of Trust approved Community Treatment cards All old copies of Community Treatment cards must be permanently filed in the notes, which are retained according to nationally defined minimum periods. Errors in Administration of Medicines In the event of a medication error, refer to the Trust Medications Error Policy Depot Medication within Community MH Services Page 8 of 16 Version 1.0 July 2017
9 Refusal of Medication In general, Patients have a right to refuse medicines. Reasons for refusal must be documented and escalated to the Patients Consultant medical team immediately and advice sought. Patients who do not attend (DNA) Clear process guidelines should be adhered to in accordance with DNA flowchart and letter (See Appendices) The Management of Depot / LAI Clinics The following guiding principles should be applied for the management of Depot/ LAI Clinics: The Depot / LAI clinic checklist is available for reference The Depot / LAI clinics should be delivered by a minimum of 2 staff. The Clinics should be delivered from a treatment/clinic room within identified central team bases. The treatment / clinic room should include appropriate waiting areas that maintain privacy and dignity and include a waiting ticket system where appropriate. The Treatment / Clinic room should be a safe and clean environment, infection control compliant, accessible with disabled access. The Treatment / Clinic room should contain emergency life support equipment and a panic alarm system. The Treatment / Clinic room should contain adequate supplies of IM medication, medical equipment, with the Patient notes available. Monitoring / Review of this Procedure In the event of planned change in the process(es) described within this document or an incident involving the described process(es) within the review cycle, this SOP will be reviewed and revised as necessary to maintain its accuracy and effectiveness. Equality Impact Assessment Please refer to overarching policy (Medicines Policy). Data Protection Act and Freedom of Information Act Please refer to overarching policy (Medicines Policy). Depot Medication within Community MH Services Page 9 of 16 Version 1.0 July 2017
10 Appendix 1 Community Depot/ Long Acting Injection Prescription and Administration Card Surname: First Name: Address: DRUG ALLERGIES AND SENSITIVITIES DO NOT LEAVE THIS SECTION BLANK Date of Birth: NHS Number: Contact Number: M/F: Signature: Print: Date: Source: None Known Community Team/Base: Consultant: Care Co-ordinator: GP: P R E S C R I P T I O N N.B. Unless otherwise directed each prescription must be reviewed and rewritten within six months from the date of prescribing DATE DRUG (GENERIC NAME) DOSE ROUTE FREQUENCY PRESCRIBER S SIGNATURE DURATION NURSING RECORD OF ADMINISTRATION DATE NEXT DUE DATE GIVEN DRUG GIVEN (GENERIC NAME) DOSE ROUTE SIGNATURE SITE/ COMMENTS Depot Medication within Community MH Services Page 10 of 16 Version 1.0 July 2017
11 Appendix 2 Depot / LAI Clinic Referral Form Please note that a referral form is required for all new Patients to the Depot Clinic Patient contact details Patient Name: Address: DOB: Relevant contacts Consultant: Community Team: Affix Label Ethnicity: Oasis Number: NHS No: Patient Contact Number: Next of kin: Care co-ordinator: Contact number: Contact number: GP: Consent to share information: yes or no Consent to have injection Contact number: Patients signature: Medication details Depot / LAI prescribed: Frequency of depot / LAI : Current dose: Next due: Any other medication: Any known allergies: Is the patient subject to CTO Date of review Any identified or historical risks: Depot Medication within Community MH Services Page 11 of 16 Version 1.0 July 2017
12 Checklist: The following paperwork is required for all new Patients to the Depot / LAI Clinic: Current Community Prescription sheet Copy of latest needs assessment and risk assessment All relevant CTO paperwork if applicable (CTO 11/12) Is the relevant treatment team aware of this referral (Circle): YES NO Name of Referrer: Contact Number: Signed referrer: Date: Depot Medication within Community MH Services Page 12 of 16 Version 1.0 July 2017
13 Appendix 3 Depot / LAI Clinic Letter for Non-Attendance Community Base Address Tel: Fax: Our ref: DNA/ NHS Number: Date: NAME ADDRESS Dear Re: Non-attendance to Depot / Long Acting Injection (LAI) Clinic We note that you did not attend Depot / LAI clinic for your depot injection on <<DATE>>. Could you please attend the next available clinic, which is held as follows: <<Treatment team name and address>> <<Day of week>> <<Time of Day>> If you are having difficulties in attending the Clinic, please contact your CPN / Care Co- Ordinator or the Duty Worker within the team on <<xxxxxxxx>> to discuss other possible ways of supporting you with this. Yours sincerely Depot / LAI Clinic Nurse XXXXXXXX Depot Medication within Community MH Services Page 13 of 16 Version 1.0 July 2017
14 Appendix 4 Community Depot / LAI Clinic Checklist PRIOR TO DEPOT / LAI CLINIC Ensure Community Treatment Card rewrites have been completed and are ready for Depot / LAI Clinic Prepare and ensure all named Patient IM medications are available Ensure all Patient notes / case record booklets are available Ensure that yellow top sharps bins are available for disposal of sharps during depot / LAI clinic ONGOING ACTIONS Ensure allergies are documented prior to administration of Depot / LAI medications Ensure prescription sheets have attached labels and up to date Patient contact details and demographic details Ensure Risperdal Consta medication reaches room temperature prior to administration (recommended 15 minutes) DNA S Adhere to DNA Flowchart for reference FOLLOWING DEPOT / LAI CLINIC Ensure all sharps bins are disposed of in accordance with Trust policies Prepare the following clinics folder Check for rewrites for the following week Order any Olanzapine/Aripiprazole injections that have been used on the day (via Penn/ Hallam Pharmacy) Order transport for the following week ref number and copy to phillip.bate@wmas.nhs.uk (where appropriate) E mail clinic list and transport list to whoever is doing clinic the following week (Wolverhampton) Ensure adequate stocks of medical equipment is available / requirement to order stocks communicated to relevant staff member Ensure filing cabinet and folders are left in an alphabetical and orderly manner Ensure adequate IM medication stocks are available / requirement to order stocks communicated to relevant staff member Tidy Clinic Area and leave it the way you d wish to find it Signed Dated. Depot Medication within Community MH Services Page 14 of 16 Version 1.0 July 2017
15 Appendix 5 Flowchart for Patients that DNA Depot/LAI Clinic Patient DNA Depot/LAI Clinic Clinic nurse to attempt phone contact Document DNA and outcome in nursing notes and on prescription sheet. RC and Care coordinator to advise 1 st DNA 2 nd DNA (Week overdue) 3+ DNA (2 weeks + overdue) Failed Telephone Contact with Patient Consider any risks Send DNA letter inviting to following weeks depot/lai clinic Telephone Contact with Patient Ascertain current mental health & reason for DNA If no concerns, Invite in to attend base/alternative clinic If concerns noted, arrange home visit Failed Telephone Contact with Patient Consider any risks Consider contacting NOK Doorstep safe and well check to be arranged by care coordinator or in absence of CC or non CPA then delegated by Team manager/deputy Team Manager Joint visit where appropriate Raise in Zoning/Team meeting Telephone contact with patient Ascertain current mental health & reason for DNA Invite in to attend base/alternative clinic Escalate to RC for discussion and further action No contact with patient Contact NOK Escalate to RC for discussion and further action Consider risks and consider safe and well check by Police if not already completed Prescription to be reviewed medically prior to administration of depot Consider OPA review Depot Medication within Community MH Services Page 15 of 16 Version 1.0 July 2017
16 Standard Operating Procedure Details Unique Identifier for this SOP is State if SOP is New or Revised BCPFT-MM-SOP-01-2 New Policy Category Executive Director whose portfolio this SOP comes under Policy Lead/Author Job titles only Committee/Group Responsible for Approval of this SOP Month/year consultation process completed Medicines Management Medical Director Community Matron Mental Health Medicines Management Committee July 2017 Month/year SOP was approved July 2017 Next review due July 2020 Disclosure Status B can be disclosed to patients and the public Review and Amendment History Version Date Description of Change 1.0 July 2017 New SOP for BCPFT Depot Medication within Community MH Services Page 16 of 16 Version 1.0 July 2017
Reconciliation of Medicines on Admission to Hospital
Reconciliation of Medicines on Admission to Hospital Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For
More informationAMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy
AMPH-PGN-10 Practice Guidance Note Intramuscular Injection (IMI) V01 Date Issued Planned Review PGN No: Issue 1 Sep 2017 Sep 2020 AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and
More informationINDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board
INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation
More informationJOB DESCRIPTION. 2. To participate in the delivery of medicines administration depending on local need and priorities.
JOB DESCRIPTION JOB TITLE: Clinical Pharmacy Technician PAY BAND: 5 DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PHARMACY/A5 University Hospitals Birmingham Pharmacy Support Manager PROFESSIONALLY RESPONSIBLE
More informationStandard Operating Procedure 5 (SOP 5) Escalation
Standard Operating Procedure 5 (SOP 5) Why we have a procedure? Escalation Escalation is the course of action that should be taken by professionals where there are concerns that the child or young person
More informationThis controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.
This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document
More informationMedicines Reconciliation Policy
Medicines Reconciliation Policy Lead executive Medical Director Authors details Senior Clinical Pharmacy Technician - 01244 39 7494 Document level: Trustwide (TW) Code: MP19 Issue number: 3 Type of document
More informationBest Practice Guidelines - BPG 9 Managing Medicines in Care Homes
Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Medicines in Care Homes 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
More informationMM12: Procedure for Ordering, Receipt, Storage and Monitoring of Medicines in the Community Teams
MM12: Procedure for Ordering, Receipt, Storage and Monitoring of Medicines in the Community Teams PROCEDURE Ratifying Committee Drugs & Therapeutics Committee Date Ratified January 2017 Next Review Date
More informationSection 136: Place of Safety. Hallam Street Hospital Protocol
MENTAL HEALTH DIVISION Section 136: Place of Safety Hallam Street Hospital Protocol 1. Introduction 2. Purpose 3. Section 136: Place of safety 4. Exclusion Criteria 5. Reception at Place of Safety 6. Initial
More informationManagement of Reported Medication Errors Policy
Management of Reported Medication Errors Policy Approved By: Policy & Guideline Committee Date of Original 6 October 2008 Approval: Trust Reference: B45/2008 Version: 4 Supersedes: 3 February 2015 Trust
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationNon Medical Prescribing Policy Register No: Status: Public
Non Medical Prescribing Policy Policy Register No: 07049 Status: Public Developed in response to: Department of Health Policies, Prescribing Guidance & Legislation Contributes to CQC Outcome: 9 Consulted
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationDr Vincent Kirchner, MEDICAL DIRECTOR. Date Version Summary of amendments Oct New Procedure
OLANZAPINE DEPOT PROCEDURE OCTOBER 2017 Policy title Policy reference Policy category Relevant to Date published Implementatio n date Date last reviewed Next review date Policy lead Contact details Accountable
More informationDOCUMENT CONTROL Patient Identification Policy 6 CL001
Title: Version: Reference Number: Scope: DOCUMENT CONTROL Patient Identification Policy 6 CL001 This policy applies to all staff who work in an inpatient setting and staff accessing inpatient wards. Purpose:
More informationNHS Fife. Patient Group Direction for Named Community Pharmacists to Supply
Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed
More informationStandard Operating Procedure
Standard Operating Procedure Title of Standard Operation Procedure (SOP): Disposal of Medicines No: SS4 Version No:3 Issue Date: June 2017 Review Date: June 2020 Purpose and Background Increasing numbers
More informationMedicines Management Policy
Medicines Management Policy Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Medicines Management Policy The Southern HSC Trust recognises that almost all patients
More informationMEDICINES RECONCILIATION GUIDELINE Document Reference
MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationFOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING
STANDARD OPERATING PROCEDURE FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING Issue History Issue Version One Purpose of Issue/Description of Change To promote safe and effective medicine administration
More informationIt is each Integrated CMHT Manager s responsibility to ensure adherence to this procedure.
Date of Next Review: 7 Apr 2019 Previous Trust/LHB Reference Number: N/A Depot Medication Procedure and Protocol for the Administration of Depot Medication in Community Mental Health Teams Reference Number:
More informationSELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING
CLINICAL PROTOCOL SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING RATIONALE Medication errors can cause unnecessary
More informationName Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019
PGD4017 PATIENT GROUP DIRECTION FOR THE SUPPLY OF ACICLOVIR TABLETS FOR THE TREATMENT OF GENITAL HERPES SIMPLEX INFECTIONS by registered nurses and midwives in Integrated Sexual Health services employed
More informationManaging medicines in care homes
Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience
More informationMedicines Prescribing Policy
Medicines Prescribing Policy Who Should Read This Policy Target Audience All Consultant/Senior Medical Staff All Junior Medical Staff All Non-Medical Prescribers All Pharmacy Staff All Ward/Unit Managers
More informationCLOZAPINE ONE STOP CLINIC POLICY (SANDWELL) Revised
1.18 CLOZAPINE ONE STOP CLINIC POLICY (SANDWELL) Policy Title State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For clinical policies only - state index category
More informationDissemination of Alerts within the Trust for Reusable Medical Devices
Standard Operating Procedure 12 (SOP 12) Dissemination of Alerts within the Trust for Reusable Medical Devices Why we have a procedure? This procedure sets out the steps to be followed to ensure that a
More informationUncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES
Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company
More informationPatient Group Direction For the supply of Fusidic Acid 2% Cream
Patient Group Direction For the supply of Fusidic Acid 2% Cream This Patient Group Direction (PGD) is a specific written instruction for the supply of Fusidic Acid 2% Cream to groups of patients who may
More informationPATIENT GROUP DIRECTION
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% FOR THE TREATMENT OF IMPETIGO BY COMMUNITY PHARMACISTS UNDER THE PHARMACY FIRST SERVICE IN NHS HIGHLAND THE COMMUNITY PHARMACIST SEEKING
More informationStandard Operating Procedure 3 (SOP 3) Template. Advance Decision To Refuse Treatment &Advance Statement
Standard Operating Procedure 3 (SOP 3) Template Advance Decision To Refuse Treatment &Advance Statement The Mental Capacity Act 2005 (MCA) provides the legal framework to empower and protect people over
More informationPre-registration. e-portfolio
Pre-registration e-portfolio 2013 2014 Contents E-portfolio Introduction 3 Performance Standards 5 Page Appendix SWOT analysis 1 Start of training plan 2 13 week plan 3 26 week plan 4 39 week plan 5 Appraisal
More informationTHE CODE. Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland. Effective from 1 March 2016
THE CODE Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland Effective from 1 March 2016 PRINCIPLE 1: ALWAYS PUT THE PATIENT FIRST PRINCIPLE 2: PROVIDE A SAFE
More informationNON MEDICAL PRESCRIBING POLICY
NON MEDICAL PRESCRIBING POLICY Document Summary This Policy provides the framework and standards for Non-Medical Prescribing. The application of this policy will ensure that all non-medical prescribers
More informationUnlicensed Medicines Policy Document
Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale
More informationDerby Hospitals NHS Foundation Trust. Drug Assessment
Drug Assessment for Preparation and Administration of Oral, Enteral, Ophthalmic, Topical, PR, PV, Inhaled, Subcutaneous and Intramuscular Medicines to Patients (N.B. The preparation and administration
More informationUnlicensed Medicines Policy
Who Should Read This Policy Target Audience All Consultant/Senior Medical Staff All Junior Medical Staff All Non-Medical Prescribers All Pharmacy Staff All Nursing Staff Version 1.0 February 2016 Ref.
More informationMedicines Management in the Domiciliary Setting (Adults)
Medicines Management in the Domiciliary Setting (Adults) DOCUMENT NO: Lead author/initiator(s): (enter job titles) Developed by: (enter Team/Group etc.) Approved by: (enter management group/committee)
More informationSection 132 of the Mental Health Act 1983 Procedure for Informing Detained Patients of their Legal Rights
Section 132 of the Mental Health Act 1983 Procedure for Informing Detained Patients of their Legal Rights DOCUMENT CONTROL: Version: 11 Ratified by: Mental Health Legislation Sub Committee Date ratified:
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for
More informationPolicy for the Reporting and Management of Incidents Including Serious Incidents. Version Number: 006
CONTROLLED DOCUMENT Policy for the Reporting and Management of Incidents Including Serious Incidents CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the principles
More informationADMITTING YOUNG PEOPLE UNDER 18 TO ADULT MENTAL HEALTH WARDS POLICY
ADMITTING YOUNG PEOPLE UNDER 18 TO ADULT MENTAL HEALTH WARDS POLICY Version: 2 Ratified By: Date Ratified: August 2015 Title of Originator/Author Title of Responsible Committee/Group Senior Managers Operational
More informationEnsuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING
Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING Contents Page 1.0 Purpose 2 2.0 Definition of medication error
More informationMedical Needs Policy. Policy Date: March 2017
Medical Needs Policy Policy Date: March 2017 Renewal Date: March 2017 Equality Statement This policy takes into account the provisions of the Equality Act 2010 and advances equal opportunities for all.
More informationNHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)
SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED
More informationMedication Management Policy and Procedures
POLICY STATEMENT This policy establishes guidelines for ensuring safe and correct management of client medications in accordance with legislative and regulatory requirements and professional practice competency
More informationNHS North Somerset Clinical Commissioning Group
NHS North Somerset Clinical Commissioning Group Medicines Policy - Safe and Secure Handling of Medicines Approved by: Quality and Assurance Group Ratification date: July 2013 Review date: June 2016 Page
More informationTranscribing Medicines for Adults Policy. Policy Register No:09076 Status: Public. NHSLA Risk Assessment standards
` Transcribing Medicines for Adults Policy Policy Register No:09076 Status: Public Developed in response to: Contributes to CQC Core Standard number: Dept of Health Medicines Regulations, NHSLA Risk Assessment
More informationHepatitis B Immunisation procedure SOP
Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical
More informationAged residential care (ARC) Medication Chart implementation and training guide (version 1.1)
Aged residential care (ARC) Medication Chart implementation and training guide (version 1.1) May 2018 Prepared by and the Health Quality & Safety Commission Version 1, March 2018; version 1.1, May 2018
More informationMedicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP Version 1, June 2017
Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP to nurses, midwives, healthcare workers, agency staff, contract workers and volunteers by registered nurses and
More informationDIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY
DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY (To be read in conjunction with Diagnostic Imaging Requesting and Interpreting Radiographs by Non Medical Practitioners Policy, Consent
More informationInforming Patients of their Rights under Section 132
Policy: I9 Informing Patients of their Rights under Section 132 Version: I9/05 Ratified by: Trust Management Team Date ratified: 12 June 2013 Title of Author: MHA Office / Health Records Manager Title
More informationSUPPORTING THE SELF-ADMINISTRATION OF MEDICATION DECEMBER 2015
SUPPORTING THE SELF-ADMINISTRATION OF MEDICATION DECEMBER 2015 This policy partially supersedes previous policies for self-medication in collaboration with the pharmacist 1 Policy title Supporting the
More informationMedicines Management in the Domiciliary Setting (Adults) Policy
Medicines Management in the Domiciliary Setting (Adults) Policy DOCUMENT NO: DN230 Lead author/initiator(s): (enter job titles) Ann Darvill Principal Pharmacist Developed by: (enter Team/Group etc.) Domiciliary
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain
More informationMedicines Reconciliation Standard Operating Procedures
Creator Sam Carvell, Amber Wynne, Sue Coppack Version 1 Review Date Medicines Reconciliation Standard Operating Procedures Purpose of SOP This standard operating procedure (SOP) provides a framework for
More informationTrial, Loan or Lease - of Medical Devices from Manufacturers/Suppliers
Standard Operating Procedure 2 (SOP 2) Trial, Loan or Lease - of Medical Devices from Manufacturers/Suppliers Why we have a procedure? There may be occasions when a Group or department wishes to trial,
More informationORAL ANTI-CANCER THERAPY POLICY
ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive
More informationMULTIDISCIPLINARY MEETINGS FOR COMMUNITY HOSPITALS POLICY
MULTIDISCIPLINARY MEETINGS FOR COMMUNITY HOSPITALS POLICY (To be read in conjunction with Handover Policy) Version: 3 Ratified by: Date ratified: August 2015 Title of originator/author: Title of responsible
More informationThe Medicines Policy. Chapter 6: Standards of Practice. MISCELLANEOUS and DISCHARGE
Chapter 6: Standards of Practice MISCELLANEOUS and DISCHARGE V2.1 Date: October 2015 CHAPTER 6 CONTENTS 6.5. Miscellaneous... 3 6.5.1 Patients Moving Between Healthcare Trusts... 3 6.5.1.1 Transfer of
More informationPrescribing Controlled Drugs: Standard Operating Procedure
Clinical Prescribing Controlled Drugs: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationHealthcare Support Workers. Administration of Medicines For Specified Children with Complex Needs in the Community
Healthcare Support Workers Administration of Medicines For Specified Children with Complex Needs in the Community Author: Children s Community Nursing Team Child Health This document in principle matches
More informationAll areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final
Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy
More informationStandard Operating Procedure
Medicines Management within CWPT Crisis Resolution and Home Treatment Teams Standard Operating Procedure Revision Chronology Version Number Effective Date Reason for Change Version 1.0 Version: Author:
More informationCh. 113 PHARMACY SERVICES 28 CHAPTER 113. PHARMACY SERVICES A. GENERAL PROVISIONS Cross References
Ch. 113 PHARMACY SERVICES 28 CHAPTER 113. PHARMACY SERVICES Subchap. Sec. A. GENERAL PROVISIONS... 113.1 This chapter cited in 28 Pa. Code 101.31 (relating to hospital requirements). Subchapter A. GENERAL
More informationCOMMUNITY PHARMACY MINOR AILMENTS SERVICE
COMMUNITY PHARMACY MINOR AILMENTS SERVICE SUPPORTING SELF-CARE OCTOBER 2010 CONTENTS Index Page No 1 Introduction 3 2 Service Specification 4 3 Consultation Procedure 7 4 Re-ordering Documentation 10 Appendices
More informationLocked Door. Target Audience. Who Should Read This Policy. All Inpatient Staff
Locked Door Who Should Read This Policy Target Audience All Inpatient Staff Version 1.0 October 2016 Ref. Contents Page 1.0 Introduction 4 2.0 Purpose 4 3.0 Objectives 4 4.0 Process for Access and Exit
More informationPatient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian
NHS Grampian Patient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian Lead Author: Consultation Group: Approver: Highly
More informationPatient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.
Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered
More informationProcedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG
Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG Introduction All health and social care organisations are accountable for ensuring the safe management of controlled drugs
More informationWhat does governance look like in homecare?
What does governance look like in homecare? Dr David Cousins PhD FRPharmS Head of Pa)ent Safety, Healthcare at Home Ltd This Satellite is sponsored by Healthcare at Home Ltd Definitions Clinical governance
More informationFamily Nurse Partnership Caseload Management
Standard Operating Procedure 5 (SOP 5) Family Nurse Partnership Caseload Management Why we have a procedure? Family Nurse Partnership (FNP) is an evidenced based licensed programme that was developed in
More informationBabylon Healthcare Services
Babylon Healthcare Services Limited Babylon Healthcare Services Ltd. Inspection report 60 Sloane Avenue London SW3 3DD Tel: 0207 1000762 Website: www.babylonhealth.com Date of inspection visit: 4 July
More informationPolicy for Patient Identification. Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled Document Lead:
CONTROLLED DOCUMENT Policy for Patient Identification CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled Document Lead: Approved By:
More informationNon medical prescribing policy. Document author Assured by Review cycle. 1. Introduction Purpose or aim Scope...3
Non medical prescribing policy Board library reference Document author Assured by Review cycle P015 Non medical prescribing lead Quality and Standards Committee 3 years This document is version controlled.
More informationGG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria:
More informationVisiting Celebrities, VIPs and other Official Visitors
Visiting Celebrities, VIPs and other Official Visitors Who Should Read This Policy Target Audience Healthcare Professionals Executive Team Version 1.0 May 2016 Ref. Contents Page 1.0 Introduction 4 2.0
More informationPOLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007:
POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007: PROVISION OF INFORMATION TO DETAINED PATIENTS Document Author Written By: Lead for Mental Health
More informationTexas Administrative Code
RULE 19.1501 Pharmacy Services A licensed-only facility must assist the resident in obtaining routine drugs and biologicals and make emergency drugs readily available, or obtain them under an agreement
More informationOn: 23 January 2012 Review Date: January 2015 Distribution: Essential Reading for: Information for:
CONTROLLED DOCUMENT Withholding Treatment Procedure (procedure for managing patients/public who are violent and/or abusive) - Yellow and Red Card Procedures CATEGORY: CLASSIFICATION: PURPOSE Controlled
More informationSTANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.
STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION. Issue History Oct 12 Issue Version Two Purpose of Issue/Description of Change To ensure implementation
More informationTRUST POLICY AND PROCEDURE FOR DETAINING HOSPITAL IN-PATIENTS UNDER SECTION 5(2) OF THE MENTAL HEALTH ACT 1983
TRUST POLICY AND PROCEDURE FOR DETAINING HOSPITAL IN-PATIENTS UNDER SECTION 5(2) OF THE MENTAL HEALTH ACT 1983 Reference Number POL-CL/1793/06 Version / Amendment History Version: 2.4.0 Status Final Author:
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Patients who require an antihistamine
More informationClinical record keeping - Adult Mental Health Inpatient Services. Standard Operating Procedure
Clinical record keeping - Adult Mental Health Inpatient Services Standard Operating Procedure DOCUMENT CONTROL: Version: 2 Ratified by: Clinical Effectiveness Committee Date ratified: 03 June 2014 Name
More informationPolicies, Procedures, Guidelines and Protocols
Policies, Procedures, Guidelines and Protocols Document Details Title Advanced Decision to Refuse Treatment Policy and Procedure (previously known as Living Wills) Trust Ref No 443-24903 Local Ref (optional)
More informationHull Collaborative Academy Trust. Medical Policy
Medical Policy Dated issued: June 2018 Ratified by the Trust Board: Review Date: June 2019 1 Other related academy policies that support this Medical policy include: Attendance, Asthma, Child Protection,
More informationMEDICATION MONITORING AND MANAGEMENT Procedures
MEDICATION MONITORING AND MANAGEMENT Procedures Waiver Programs Purpose To support persons served in their own homes with their medication needs. Scope This procedure applies to all Waiver employees who
More informationNon-Medical Prescribing Passport. Reflective Log And Information
Non-Medical Prescribing Passport Reflective Log And Information Non-Medical Prescribing Continued Profession Development Log NMPs must refer to their regulatory bodies requirements for maintaining and
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationPROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS
PROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS Policy Details NHFT document reference MMPr030 Version 22/02/16 Date Ratified May 2016
More informationBest Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse
More informationMedicines Governance Service to Care Homes (Care Home Service)
Medicines Governance Service to Care Homes (Care Home Service) Locally Enhanced Service Authors: Ruth Buchan, Senior Pharmacist Medicines Management 4th Floor F Mill Dean Clough Halifax HX3 5AX Tel-01422
More informationMandatory Competency Assessment for Medicines Management (Not Injectable Medicines) for Registered Practitioners IN HOSPITAL
Mandatory Competency Assessment for Medicines Management (Not Injectable Medicines) for Registered Practitioners IN HOSPITAL Document Author Written by: Lead Pharmacist/Lead Technician Medicines Use and
More information